EVENTS & MEDIA
IN THE NEWS
Avara Liscate: High Standards and Expertise in Sterile Manufacturing.
Avara Pharmaceutical Services’ Liscate, Italy sterile manufacturing facility completed several successful regulatory inspections in 2019. We continue to build on our high standards and extensive expertise to deliver high-quality products to patients.
June 2020 | News
How is Avara Preparing to Face the Future of Healthcare?
Avara, one of Our Road to CPhI Milano sponsors discuss how they are preparing to face the future of healthcare.
June 2020 | Thought Leadership
Avara CEO Talks Outsourcing Trends & Company Highlights with Contract Pharma
Our CEO, Larry Lee, recently shared company highlights, as well as his thoughts about trends in outsourcing and OSD & Steriles markets with Contract Pharma.
May 2020 | Thought Leadership
Concentrating on Core OSD & Sterile Capabilities for Assured Client Success
With a solid base of oral solid dose and sterile manufacturing and packaging expertise that includes four state-of-the-art facilities delivering two billion patient doses annually, Avara Pharmaceutical Services has refocused to leverage its core ...
April 2020 | News
Avara Liscate Delivers Critical Care Drugs to Covid-19 Patients
The Covid-19 pandemic has created significant operational and logistical challenges for the pharmaceutical and healthcare industries worldwide. Despite these challenges, across Avara, all facilities have been safely and successfully maintaining ...
March 2020 | News
Avara Offers Clients Virtual Visits to Solve Site Audit Challenges
As part of Avara’s Business Continuity actions, our goal is to support the delivery of all key project milestones, in order to minimize impact from Coronavirus (Covid-19) prevention measures. Where current restrictions may prevent a site visit or audit ...
February 2020 | News
2019: A Transformative Year for Avara, Paving the Way for a Strong 2020.
In 2019, Avara refocused the business on its core capabilities within Oral Solid Dose and Sterile and this resulted in an annual EBITDA of $30.7M (unaudited), at 15% on revenues of $203M, with positive contributions from every Avara facility.
January 2020 | News
Avara Liscate Facility Welcomes 2020 On a High!
Avara’s Liscate facility provides sterile manufacturing, fill-finish, and packaging services for supply to European, United States, Canadian, and Latin American markets. During Q4 2019, the facility hosted the US FDA as part of a Pre-Approval Inspection ...
Avara Pharmaceutical Services, Inc.
3300 Marshall Avenue
Norman, OK 73072
© 2020 Avara Pharmaceutical Services, Inc.
All Rights Reserved